News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Daxor Corporation (Nasdaq: DXR) announced the launch of a new outpatient Blood Volume Analysis (BVA) program in eastern Kansas, expanding its presence in Midwestern outpatient care. This initiative utilizes Daxor's turnkey ezBVA Lab send-out model, offering quick and accurate blood volume measurements without requiring …
Daxor Corporation has launched a new outpatient Blood Volume Analysis (BVA™) program at a major healthcare facility in eastern Kansas, aiming to enhance precision diagnostics and patient outcomes in the Midwest. This initiative utilizes the ezBVA Lab send-out model, allowing healthcare providers to obtain …
Daxor Corporation has launched its ezBVA Lab diagnostic service in eastern Kansas, offering precise outpatient blood volume analysis. This service provides clinicians with 98% accurate measurements of blood, plasma, and red cell volume within 24 hours, without requiring capital equipment from the healthcare facility. …
Daxor Corporation has launched an outpatient Blood Volume Analysis (BVA) program in eastern Kansas, providing 98% accurate blood volume measurements within 24 hours. This service uses a CLIA-certified send-out model, eliminating the need for capital equipment at outpatient practices and aiming to improve patient …
This article provides a technical analysis of Daxor Corp (DXR), focusing on various indicators and moving averages to assess its current market status. It details specific indicator values for MACD, RSI, KDJ, ATR, CCI, Williams %R, TRIX, and StochRSI, along with moving average values …
This article provides a revenue breakdown for Daxor Corp (DXR), detailing its business segments, regional revenue, and profit contribution. However, it notes that relevant data for these breakdowns have not yet been disclosed by the company. The page also presents current stock information for …
This article provides the quarterly and annual balance sheets for Daxor Corp (DXR), allowing users to assess the company's financial health, liquidity, leverage, and return on equity. It includes detailed financial data for various line items such as total equity, restricted cash, assets, liabilities, …
This article provides a comprehensive financial overview of Daxor Corp (DXR), detailing its income statement, balance sheet, and cash flow statement. It highlights key financial indicators like EPS, revenue, net profit, and various margins, alongside projected earnings and analyst ratings. The report is designed …
This article provides a detailed income statement for Daxor Corp (DXR), showing quarterly and annual financial performance data. It includes key metrics such as total revenue, operating expenses, operating profit, net income, and earnings per share across multiple fiscal years. The article also features …
This article provides a risk assessment for Daxor Corp (DXR), detailing various metrics related to volatility, financial risk, and investment risk. Key data points include Beta vs S&P 500 index, VaR, maximum drawdown, daily returns, Sharpe Ratio, and liquidity measures such as average turnover …
This article from TradingKey provides a valuation analysis for Daxor Corp (DXR), detailing its market capitalization and P/E TTM ratio. It notes that relevant data for P/E, P/B, and P/S ratios have not yet been disclosed by the company. The page also presents key …
The article provides an overview of Daxor Corp (DXR) stock, highlighting its institutional confidence section. It details key shareholder activities, including major holders like Joseph Feldschuh UEO and other institutional investors such as Renaissance Technologies LLC and Morgan Stanley Smith Barney LLC, along with …
This article provides details on Daxor Corp (DXR) stock, indicating its current market price, market cap, and P/E ratio. It highlights that the company has not distributed any dividends over the past five years and contains no specific information on stock splits. The article …
This article presents the annual and quarterly cash flow statements for Daxor Corp (DXR), including detailed financials for operating, investing, and financing activities across several fiscal years. It also defines key cash flow terms and provides answers to frequently asked questions about Daxor Corp's …
Daxor Corp (DXR) is currently trading at $10.45, up 3.27% on the day, with a market capitalization of $61.01M. Analysts have a "Buy" rating for DXR with a target price of $22.50, representing a significant upside. The company specializes in blood volume measurement technology, …
This article summarizes Daxor's (DXR) proxy filing, detailing an upcoming Annual Meeting on June 23, 2026. Key agenda items include the election of six directors and the ratification of Bush & Associates, CPA as the independent auditor for 2026. The filing also outlines corporate …
Search by ticker symbol or company name and select a result to open its chart.